Osteoarthritis therapy study advances with $17 million from ARPA-H
October 14, 2026
October 14, 2026
ST. LOUIS, Missouri, Oct. 14 -- Washington University in St. Louis posted the following news:
* * *
Osteoarthritis therapy study advances with $17 million from ARPA-H
*
* WashU Medicine has received $17 million from ARPA-H to develop an injectable osteoarthritis treatment.
* The nanoparticle-based therapy regenerates damaged joint tissue.
* In collaboration with CRISPR Therapeutics and SynGenix, the team is preparing t . . .
* * *
Osteoarthritis therapy study advances with $17 million from ARPA-H
*
* WashU Medicine has received $17 million from ARPA-H to develop an injectable osteoarthritis treatment.
* The nanoparticle-based therapy regenerates damaged joint tissue.
* In collaboration with CRISPR Therapeutics and SynGenix, the team is preparing t . . .